Antineoplastics

Ocular adverse events: 40 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Kim YJ, et al. Factors associated with ocular adverse event after immune checkpoint inhibitor treatment. Cancer Immunology Immunotherapy 69: 2441-2452, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1007/s00262-020-02635-3

      Article  Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Antineoplastics. Reactions Weekly 1838, 60 (2021). https://doi.org/10.1007/s40278-021-89379-2

    Download citation